Gallagher Carol Giltner 4

What Happened Carol Giltner Gallagher, a director of PMV Pharmaceuticals (PMVP), was granted 42,000 derivative securities (a stock option/award) on June 4, 2026 at a $0 per-share reporting price (aggregate $0). The same day she recorded a gift transfer of those 42,000 derivative shares into The Gallagher Revocable Trust (for which she serves as trustee), producing both an acquisition (award) and a disposition (gift) entry in the filing. The award is subject to vesting.

Key Details

• Transaction date: June 4, 2026; Filing date: June 5, 2026 (timely).
• Transactions reported: A (award/grant) 42,000 derivative shares @ $0.00 (acquired); G (gift) 42,000 derivative shares @ $0.00 (disposed); G (gift) 42,000 derivative shares @ $0.00 (acquired by trust).
• Vesting: These derivative shares vest on the earlier of (i) June 4, 2027 or (ii) the issuer’s next annual meeting of stockholders (Footnote F1).
• Record ownership: The securities are held of record by The Gallagher Revocable Trust dated May 10, 2011, for which Gallagher is trustee (Footnote F2).
• Shares owned after the transaction: not specified in the filing.
• Filing timeliness: appears timely (no late filing flag).

Context

• These were derivative awards (options/awards) subject to future vesting — not an open-market purchase or sale. No cash changed hands in the reported entries.
• The award followed immediately by a gift to a revocable trust is an internal transfer and does not necessarily indicate a change in Gallagher’s economic exposure or market sentiment.
• Gifts are not the same as sales and are commonly used for estate or trust planning; they do not imply a bullish or bearish investment signal.